EUVIMEDEUVIMED entdecken
Crossref

Prenatal Exposure to Acid Suppressor Medications and Development of Ductus Arteriosus in Term Newborns

Ella Segal iD, Daniella Landau, Lior Hassan, Adir Israeli, Rafael Gorodischer

American Journal of Perinatology · 01.11.2024 · 41 (15) · 2091-2097

DOI: 10.1055/a-2295-6339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.11.2024. Verfasst von Ella Segal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Joyce and Irving Goldman Medical School, The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. Hauptthemen laut MEDLINE: Ductus Arteriosus, Patent, Proton Pump Inhibitors, Histamine H2 Antagonists, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The ductus arteriosus normally closes after birth. Histamine 2 receptor antagonist (H2RA) has been associated with patent ductus arteriosus (PDA). We aimed to study the characteristics of term infants with PDA and their possible association with prenatal exposure to antacids—proton pump inhibitors (PPIs) and H2RA. Study Design This was a population-based matched case–control study of mothers registered at “Clalit” Health Maintenance Organization (HMO) and their infants born at “Soroka” University Medical Center (SUMC) between 2001 and 2018. Cases are defined as term infants born with PDA diagnosed by echocardiography and registered in the postdelivery discharge form. Each case was matched with four term newborns without PDA diagnosis. Exposure window was defined by the timing of first purchase of H2RA or PPI during pregnancy and based on information from a computerized medication database (Clalit HMO, SUMC).

Results

PDA was diagnosed in 1,884 term infants (4.9%). Characteristics included a significantly higher percentage of lack of prenatal care, cesarean section, in vitro fertilization, polyhydramnios, oligohydramnios, Apgar 1 minute

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ductus Arteriosus, PatentProton Pump InhibitorsHistamine H2 AntagonistsPrenatal Exposure Delayed EffectsHumansFemaleInfant, NewbornPregnancyCase-Control StudiesAdultMaleTerm BirthIsraelRisk Factors

Substanzen

Proton Pump InhibitorsHistamine H2 Antagonists

Autor:innen und Institutionen

  • Joyce and Irving Goldman Medical School, The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Department of Neonatology, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

ORCID-Profile: Ella Segal

Zitieren

APA

Segal, E., Landau, D., Hassan, L., Israeli, A., & Gorodischer, R. (2024). Prenatal Exposure to Acid Suppressor Medications and Development of Ductus Arteriosus in Term Newborns. American Journal of Perinatology, 41(15), 2091-2097. https://doi.org/10.1055/a-2295-6339

Vancouver

Segal E, Landau D, Hassan L, Israeli A, Gorodischer R. Prenatal Exposure to Acid Suppressor Medications and Development of Ductus Arteriosus in Term Newborns. American Journal of Perinatology. 2024;41(15):2091-2097. doi:10.1055/a-2295-6339

BibTeX
@article{Segal2024,
  author = {Segal, Ella and Landau, Daniella and Hassan, Lior and Israeli, Adir and Gorodischer, Rafael},
  title = {Prenatal Exposure to Acid Suppressor Medications and Development of Ductus Arteriosus in Term Newborns},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {15},
  pages = {2091--2097},
  doi = {10.1055/a-2295-6339}
}
Kostenlos starten →